Ensysce Biosciences Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ENSC
Share price (8/19/26): $0.39
Market cap (8/19/26): $7.549 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 83 pages Agreement and Plan of Merger by and Among: Ensysce Biosciences, Inc., a Delaware Corporation; Phrma Merger Sub I, Inc., a Delaware Corporation; Phrma Merger Sub II, LLC, a Delaware Limited Liability Company; and CY Biopharma, Inc., a Delaware Corporation Dated as of August 5, 2026

from SC 13G/A 5 pages Power of Attorney for Executing Schedules 13g and 13d, 13g/D Joint Filing Agreement and Form 13f

from 8-K 93 pages Agreement and Plan of Merger Dated as of January 31, 2021 by and Among Ensysce Biosciences, Inc., Eb Merger Sub, Inc. and Leisure Acquisition Corp

from 425 93 pages Agreement and Plan of Merger Dated as of January 31, 2021 by and Among Ensysce Biosciences, Inc., Eb Merger Sub, Inc. and Leisure Acquisition Corp

from 8-K 225 pages Agreement and Plan of Merger Dated as of December 27, 2019 by and Among Gtwy Holdings Limited, Gtwy Merger Sub Corp. and Leisure Acquisition Corp

from 425 225 pages Agreement and Plan of Merger Dated as of December 27, 2019 by and Among Gtwy Holdings Limited, Gtwy Merger Sub Corp. and Leisure Acquisition Corp